BRAIDEN FAIRBANKS: Open Payments
NPI 1164017679 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 20 payments from 12 companies in 2025. Trend: 2023 $2,229 · 2024 $2,541 · 2025 $928
Food & beverage: $928
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $244 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $163 |
| Lilly USA, LLC | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $113 |
| GENZYME CORPORATION | 2 | $63 |
| Ardelyx, Inc. | 2 | $49 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: SKYRIZI, ENTYVIO, OMVOH, TREMFYA, DUPIXENT, IBSRELA, REBYOTA, IQIRVO.
Industry payments across AZ — which companies pay providers there.
